FDA’s AI Black Box: Investing in Explainable Clinical Decision Support
Can a physician legally and safely rely on an AI recommendation they cannot explain? This question, once confined to academic discourse, now sits squarely at…
Can a physician legally and safely rely on an AI recommendation they cannot explain? This question, once confined to academic discourse, now sits squarely at…
The FDA has harmonized its Quality System Regulation (QSR) with the international standard ISO 13485, and the new Quality Management System Regulation (QMSR) is now…
The regulatory field for medical devices, particularly for sophisticated AI-driven health tools, is undergoing a deep transformation. Quality assurance managers, regulatory compliance officers, and medical…
The promise of artificial intelligence in healthcare is inextricably linked to its sustained performance in the real world. While initial premarket clearance for AI-powered Software…
The field of digital health procurement for hospitals and health systems is undergoing a deep transformation, driven by evolving regulatory clarity from the FDA. What…
The field of AI-driven medical devices is undergoing a seismic shift, with the FDA asserting unprecedented authority over cybersecurity. This isn’t merely an advisory update.…
The promise of AI in healthcare is immense, yet its clinical integration hinges on more than just algorithmic prowess. For AI-driven Software as a Medical…
The promise of artificial intelligence in cardiovascular health is undeniable, offering unprecedented capabilities for early detection, personalized treatment, and improved patient outcomes. However, the path…
The FDA had issued a final rule to regulate Laboratory Developed Tests (LDTs) that was intended to fundamentally redefine the oversight field for diagnostic technologies.…
The promise of adaptive machine learning (ML) in Software as a Medical Device (SaMD) is deep: algorithms that continually learn and improve postmarket, enhancing diagnostic…